HBV-IN-35
HBV-IN-35 (Compound 88) is a HBV inhibitor. HBV-IN-35 has anti-HBV activities in mouse and human hepatocytes (EC50: 100 nM and 400 nM respectively) [1].
Product Specifications
UNSPSC
12352005
Target
HBV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/hbv-in-35.html
Solubility
10 mM in DMSO
Smiles
O=C(NC1=CC(C(F)F)=C(F)C=C1)N2C(CN3CCC(F)(F)CC3)CNC4=C2C=CC=C4
Molecular Formula
C22H23F5N4O
Molecular Weight
454.44
References & Citations
[1]Hwang N, et al. Identification of novel tetrahydroquinoxaline derived phenyl ureas as modulators of the hepatitis B virus nucleocapsid assembly. Eur J Med Chem. 2023 Jul 17;259:115634.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TRC-A603315-10MG 10 mg
6-Amino-4-(3-chloro-4-fluoroanilino)-3-cyano-7-ethyloxyquinoline
Sign In for Pricing
View Details 
KN200145 1 Kit
Ceramide synthase 2 (CERS2) Human Gene Knockout Kit (CRISPR)
Sign In for Pricing
View Details 
